We next assessed the quality of the T cell response generated during latent infection by analyzing the activation state of CD4+ T-cells in infected lungs after 6 weeks of rifampicin and isoniazid treatment, and a further 3 weeks of infection reactivation. This evidence concerns the gene CD4 and disease arising from reactivation of latent virus.